Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer Journal Article


Authors: Skoulidis, F.; Li, B. T.; de Langen, A. J.; Hong, D. S.; Lena, H.; Wolf, J.; Dy, G. K.; Curioni Fontecedro, A.; Tomasini, P.; Velcheti, V.; van der Wekken, A. J.; Dooms, C.; Paz-Ares Rodriguez, L.; Mountzios, G.; Sacher, A.; Nadal, E.; Couraud, S.; Kim, S. W.; O’Byrne, K.; Rocco, D.; Toyozawa, R.; Chmielewska, I.; Lindsay, C. R.; Hindoyan, A.; Mukundan, L.; Wilmanski, T.; Anderson, A.; Ardito-Abraham, C.; Pati, A.; Reddy, A.; Mehta, B.; Schuler, M.
Article Title: Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer
Abstract: Molecular determinants of KRAS(G12C)inhibitor efficacy in KRASG12C-mutated non-small-cell lung cancer (NSCLC) remain poorly characterized. Here we report one of the largest integrated analyses to date of sotorasib clinical efficacy biomarkers from the phase 2 CodeBreaK 100 and phase 3 CodeBreaK 200 studies. We reveal differential sotorasib activity and relative benefit compared to docetaxel across KRASG12C-mutated NSCLC co-mutational subsets and transcriptional subtypes. We also identify low expression of TTF1 and KEAP1 co-mutations/NRF2 activation as major determinants of sotorasib anti-tumor efficacy and adverse prognostic features. Exploratory analyses highlight potential tumor cell-extrinsic contributors to sotorasib anti-tumor activity and suggest that early on-treatment clearance of KRASG12C- circulating tumor DNA may refine clinical response prediction algorithms. Our findings advance precision medicine for patients with KRASG12C-mutated NSCLC and establish a framework for patient stratification and selection for treatment intensification with rationally applied therapeutic combinations. © The Author(s) 2025.
Journal Title: Nature Medicine
ISSN: 1078-8956
Publisher: Nature Publishing Group  
Publication status: Online ahead of print
Date Published: 2025-05-28
Online Publication Date: 2025-05-28
Language: English
DOI: 10.1038/s41591-025-03732-5
PROVIDER: scopus
PUBMED: 40437272
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    279 Li